KIF21B and chronic myelogenous leukemia, BCR-ABL1 positive: KIF21B has been studied at the single-cell level in 12 kinds of cancer (Figure 5(a)), including AML, ALL, CML, GBM, Glioma, AST, ODG, LUAD, MEL, RCC, BRCA, and PC.